Holen Sie sich die Stockscreener-App
7.10
0.85%
0.06
Handel nachbörslich:
6.98
-0.12
-1.69%
Schlusskurs vom Vortag:
$7.04
Offen:
$7.08
24-Stunden-Volumen:
179.66K
Relative Volume:
0.40
Marktkapitalisierung:
$474.94M
Einnahmen:
$555.06M
Nettoeinkommen (Verlust:
$-39.48M
KGV:
-11.83
EPS:
-0.6
Netto-Cashflow:
$29.05M
1W Leistung:
-2.07%
1M Leistung:
+12.34%
6M Leistung:
-29.63%
1J Leistung:
-26.50%
1-Tages-Spanne:
$6.99
$7.13
1-Wochen-Bereich:
$6.99
$7.485
52-Wochen-Spanne:
$5.81
$14.38
Bioventus Inc Stock (BVS) Company Profile
Firmenname
Bioventus Inc
Sektor
Branche
Telefon
(919) 474-6700
Adresse
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Vergleichen Sie BVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
7.10 | 482.96M | 555.06M | -39.48M | 29.05M | -0.60 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-17 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-12-07 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | Hochstufung | Craig Hallum | Hold → Buy |
| 2022-11-22 | Herabstufung | Craig Hallum | Buy → Hold |
| 2022-11-09 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-03-15 | Eingeleitet | Craig Hallum | Buy |
| 2021-11-15 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-11-10 | Fortgesetzt | JP Morgan | Overweight |
| 2021-07-01 | Herabstufung | Goldman | Buy → Neutral |
| 2021-03-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-03-08 | Eingeleitet | Goldman | Buy |
| 2021-03-08 | Eingeleitet | JP Morgan | Overweight |
| 2021-03-08 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Bioventus Inc Aktie (BVS) Neueste Nachrichten
Bioventus Inc. stock trendline breakdownJuly 2025 Spike Watch & Accurate Intraday Trade Tips - Newser
Will Bioventus Inc. bounce back from current support2025 Trading Recap & High Accuracy Trade Signal Alerts - Newser
Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - The Manila Times
Global Active Healing Leader Bioventus to Present at Morgan Stanley's 23rd Healthcare Conference - Stock Titan
Published on: 2025-09-03 04:15:11 - Newser
Visualizing Bioventus Inc. stock with heatmapsPortfolio Value Summary & Weekly Chart Analysis and Trade Guides - Newser
Applying sector rotation models to Bioventus Inc.Weekly Profit Analysis & Daily Chart Pattern Signal Reports - Newser
Key metrics from Bioventus Inc.’s quarterly dataBond Market & Comprehensive Market Scan Insights - Newser
Real time scanner hits for Bioventus Inc. explainedJuly 2025 Closing Moves & High Accuracy Trade Alerts - Newser
How to monitor Bioventus Inc. with trend dashboards2025 Market WrapUp & High Accuracy Swing Entry Alerts - Newser
Bioventus Inc. recovery potential after sell offJuly 2025 Action & Weekly High Potential Alerts - Newser
Bioventus Inc. stock outlook for YEARProduct Launch & Daily Entry Point Alerts - Newser
Returns Recap: Can Bioventus Inc. maintain sales growthMarket Activity Summary & Advanced Technical Signal Analysis - khodrobank.com
What makes Bioventus Inc. stock price move sharplyJuly 2025 PostEarnings & Community Consensus Trade Alerts - Newser
Will Bioventus Inc. benefit from sector rotationEarnings Beat & Expert Approved Trade Ideas - khodrobank.com
Candlestick signals on Bioventus Inc. stock todayQuarterly Market Summary & Daily Stock Trend Watchlist - Newser
What indicators show strength in Bioventus Inc.July 2025 News Drivers & Entry and Exit Point Strategies - Newser
Detecting support and resistance levels for Bioventus Inc.Quarterly Investment Review & AI Forecasted Stock Moves - Newser
Should I buy Bioventus Inc. stock now2025 AllTime Highs & Weekly Setup with High ROI Potential - khodrobank.com
Bioventus Inc. stock volume spike explained2025 Stock Rankings & Weekly Setup with ROI Potential - Newser
What’s next for Bioventus Inc. stock priceNew Guidance & AI Driven Stock Movement Reports - Newser
Published on: 2025-09-01 03:23:38 - Newser
Published on: 2025-09-01 00:02:39 - Newser
Gains Recap: Will Bioventus Inc. outperform the market in YEARDip Buying & Smart Money Movement Tracker - kpenews.com
Key resistance and support levels for Bioventus Inc.Index Update & Safe Swing Trade Setup Alerts - Newser
Is it time to cut losses on Bioventus Inc.July 2025 PreEarnings & Long Hold Capital Preservation Plans - Newser
How to forecast Bioventus Inc. trends using time seriesQuarterly Trade Summary & Advanced Swing Trade Entry Alerts - Newser
Technical analysis overview for Bioventus Inc. stockRisk Management & Reliable Entry Point Trade Alerts - Newser
Published on: 2025-08-30 23:07:02 - Newser
Published on: 2025-08-30 21:14:48 - Newser
Using Ichimoku Cloud for Bioventus Inc. technicals2025 EndofYear Setup & Accurate Entry and Exit Point Alerts - Newser
Is Bioventus Inc. reversing from oversold territory2025 Market Trends & Expert Curated Trade Ideas - Newser
Finanzdaten der Bioventus Inc-Aktie (BVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bioventus Inc-Aktie (BVS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Bartholdson John A. | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
72,045 |
| SUTTER MARTIN P | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
85,241 |
| STALNECKER SUSAN M | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
105,957 |
| NOHRA GUY P | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
126,610 |
| NEELS GUIDO J | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
85,241 |
| McMurry-Heath Michelle | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
74,698 |
| Ladone Mary Kay | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
78,981 |
| HAWKINS WILLIAM A | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
257,851 |
| Beyer Pat | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
76,436 |
| Singleton Mark Leonard | SVP & CFO |
Apr 11 '25 |
Sale |
7.57 |
3,875 |
29,334 |
141,088 |
0.38%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):